Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy

NCT02351115 is registered in ClinicalTrials.gov with Nova Pneuma Inc. as lead sponsor.

NCT NCT02351115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02351115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Lead sponsor
Nova Pneuma Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2015
Completion date
July 31, 2016
Enrollment
5 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy